Crystalline L-MGDA Trialkali Salt via Enantiomer Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for producing crystalline complexing agents like methylglycine diacetic acid (MGDA) trialkali metal salts are complex and costly due to inhibition by asymmetric molecular shapes, leading to hygroscopic and poorly processable amorphous solids, especially when using racemic forms which require expensive equipment and result in unstable products.

Innovation Solution

A process involving the crystallization of the L-enantiomer of α-alanine, converted through the Strecker synthesis and alkaline saponification to form the L-MGDA trisodium salt, is used, ensuring temperatures do not exceed 150°C during alkaline hydrolysis to prevent racemization, allowing for easy crystallization and production of stable, non-hygroscopic crystalline forms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If crystallization is used to produce solid MGDA from aqueous solution, then solid form is obtained, but the crystalline solids contain water of crystallization and are less stable under ambient conditions

Engineering Contradiction:
Improvesolid formVSAvoidstability under ambient conditions
Core Design Contradiction:
ShapeVSStability of the object's composition

Solution Approach 1:

The patent changes the molecular configuration parameter from racemic (DL) to pure L-enantiomer form, which fundamentally alters the crystallization behavior and stability characteristics of the MGDA salt, enabling production of stable crystalline solids without water of crystallization

Inventive Principle:
Principle #35Parameter changes

2Productivity

If spray drying is used to produce solid MGDA from aqueous solution, then solid form is obtained quickly, but the solid is highly hygroscopic and loses free-flowing properties when stored

Engineering Contradiction:
Improveproduction speedVSAvoidhygroscopicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the enantiomeric composition parameter to pure L-form, which fundamentally alters the physical and chemical properties of the product, making it non-hygroscopic and free-flowing while maintaining efficient production

Inventive Principle:
Principle #35Parameter changes

3Productivity

If racemic MGDA is crystallized, then production can proceed, but the asymmetric molecular shape strongly inhibits crystallization requiring complex and expensive equipment

Engineering Contradiction:
Improvecrystallization capabilityVSAvoidequipment complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent changes the stereochemical parameter from racemic mixture to pure L-enantiomer, which transforms the crystallization process from inhibited and complex to spontaneous and simple, allowing conventional equipment to be used

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts the D-enantiomer component from the racemic mixture, leaving only the L-enantiomer which crystallizes readily, thereby eliminating the crystallization inhibition caused by asymmetric molecular shapes

Inventive Principle:
Principle #2Taking out (Extraction)

4Productivity

If temperature during alkaline saponification exceeds 150°C, then reaction rate increases, but racemization occurs compromising the L-enantiomer purity

Engineering Contradiction:
Improvereaction rateVSAvoidenantiomer purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes the temperature parameter to remain below 150°C during alkaline saponification, finding the optimal balance between reaction rate and prevention of racemization, thereby maintaining high L-enantiomer purity while achieving acceptable productivity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method results in better control over crystallization, improved morphology, higher purity, and enhanced storage and transport properties, with three-dimensional crystals that are easier to process and handle compared to needle-like forms obtained from racemate crystallization, reducing the risk of clogging and improving yield and centrifugability.

Implementation Method 1

L-α-alanine, which is reacted with formaldehyde and hydrogen cyanide to form L-α-alanine-N,N-diacetonitrile according to Strecker synthesis

Methodology Applied
Scientific EffectStrecker synthesis: Chemical Bonding

Implementation Method 2

subsequently the L-α-alanine-N,N-diacetonitrile is saponified to form the L-MGDA trisodium salt under alkaline conditions

Methodology Applied
Scientific EffectAlkaline saponification: Hydrolysis

Implementation Method 3

the crystallization of L-MGDA trisodium salt proceeds with significant advantages compared to the corresponding racemate

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 4

evaporation crystallization can advantageously be used

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentEP2705022B2Process for preparing a crystalline l-mgda tri-alkali metal salt
Publication Date: 2021.04.28 BASF SE
  • EP2705022B2 patent drawingFigure 1~2
  • EP2705022B2 patent drawingFigure 3

AI summary

What is proposed is a process for preparing a crystalline L-MGDA tri-alkali metal salt by crystallization from an aqueous solution thereof which has been obtained by Strecker synthesis proceeding from L-a-alanine, by reaction with formaldehyde and hydrogen cyanide to give L-a-alanine-N,N-diacetonitrile and subsequent alkaline hydrolysis of the L-a-alanine-N,N-diacetonitrile to give the L-MGDA tri-alkali metal salt, which is characterized in that a temperature of 150°C is not exceeded in the course of alkaline hydrolysis.